Compounds > tanshinone ii a
Page last updated: 2024-09-05

tanshinone ii a and 6-o-palmitoylascorbic acid

tanshinone ii a has been researched along with 6-o-palmitoylascorbic acid in 1 studies

Compound Research Comparison

Studies
(tanshinone ii a)		Trials
(tanshinone ii a)		Recent Studies (post-2010)
(tanshinone ii a)		Studies
(6-o-palmitoylascorbic acid)		Trials
(6-o-palmitoylascorbic acid)		Recent Studies (post-2010) (6-o-palmitoylascorbic acid)
61041205688

Protein Interaction Comparison

ProteinTaxonomytanshinone ii a (IC50)6-o-palmitoylascorbic acid (IC50)
60 kDa heat shock protein, mitochondrialHomo sapiens (human)3.1
Caspase-1Homo sapiens (human)0.6
10 kDa heat shock protein, mitochondrialHomo sapiens (human)3.1
60 kDa chaperonin Escherichia coli6
10 kDa chaperonin Escherichia coli6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A1

Other Studies

1 other study(ies) available for tanshinone ii a and 6-o-palmitoylascorbic acid

ArticleYear
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
    Bioorganic & medicinal chemistry letters, 2019, 05-01, Volume: 29, Issue:9

    Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin

2019